Xtant Medical

INVESTORS

HomeInvestors

INVESTORS

Click here for Webcast
Xtant Medical First Quarter 2022 Financial Results
 05/05/22  9:00 AM EDT

Corporate Profile

Xtant Medical Holdings, Inc. (NYSE MKT: XTNT) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries.

Stock Quote

(Common Stock)
Price
Change (%)
Volume
Data as of  

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Stock Chart

Recent News

Date Title  
Toggle Summary Xtant Medical Announces First Quarter 2022 Financial Results
BELGRADE, Mont. , May 05, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the first quarter ended March 31, 2022 .
Toggle Summary Xtant Medical Appoints Scott Neils as Chief Financial Officer
BELGRADE, Mont. , May 02, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the appointment of Scott Neils as Chief Financial Officer, effective June
Toggle Summary Xtant Medical to Issue First Quarter 2022 Financial Results on May 5, 2022
BELGRADE, Mont. , April 28, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended
Toggle Summary Xtant Medical to Present at the Canaccord Musculoskeletal Conference on March 22, 2022
BELGRADE, Mont. , March 15, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne , President and Chief Executive Officer, will present at
More
Upcoming Events
There are currently no events scheduled.
More

Receive Email Alerts

Sign up to receive email alerts whenever Xtant Medical Holdings Inc posts new information to the site. Just enter your email address and click Submit.